CareMax Reports Second Quarter 2023 Results

Go back to CareMax Reports Second Quarter 2023 Results

CareMax (CMAX) Misses Q2 EPS by 21c; Offers FY23 Revenue Guidance

August 9, 2023 6:57 AM EDT

CareMax (NASDAQ: CMAX) reported Q2 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $224.4 million versus the consensus estimate of $184.41 million.

GUIDANCE:

CareMax sees FY2023 revenue of $750-800 million, versus the consensus of $740... More